Showing results (3211-3220 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|January 1, 1996
Combinations of ganciclovir and antibody for experimental CMV infectionsF S Stals, S S Wagenaar, J S Kloover, et al.Antiviral Research|January 1, 1996
Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trialD A JabsAntiviral Research|October 23, 2004
Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivoFrank Notka, Georg Meier, Ralf WagnerAntiviral Research|October 23, 2004
A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virusHåvard Jenssen, Jeanette H Andersen, Dimitris Mantzilas, et al.Antiviral Research|October 23, 2004
Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected miceAndreas Henke, Chi-Shiun Chiang, Roland Zell, et al.Antiviral Research|June 1, 2004
Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different cladesMei-Yun Zhang, Yuuei Shu, Igor Sidorov, et al.Antiviral Research|June 1, 2004
Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virusKazufumi Kimura, Ken Ishioka, Koichi Hashimoto, et al.Antiviral Research|June 1, 2004
Persistence of mutations during replication of an HIV library containing combinations of selected protease mutationsWei Song, Yosuke Maeda, Akira Tenpaku, et al.Antiviral Research|June 1, 2004
Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAARTJan-Christian Wasmuth, Hans-Dieter Nischalke, Alexander Jütte, et al.Antiviral Research|August 11, 2004
3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signalingDavid L Evers, Xin Wang, Shu-Mei Huong, et al.Pageof 523